The human growth hormone (hGH-N) and the closely related human growth hormone-variant (hGH-V) genes differ in their patterns of splice-site selection. In 9% of hGH-N transcripts exon 2 is spliced to an alternative acceptor site located 45 bases within exon 3. mRNA spliced in this manner encodes a 20-kDa hGH-N isoform instead of the normal 22-kDa hGH-N. The hGH-V transcript fails to utilize this alternative splicing pathway. A region of the hGH-N and hGH-V genes critical to this difference in splice-site selection has been identified by reciprocal exchange of corresponding genomic fragments and has been defined in detail by a series of reciprocal site-specific exchanges. Three base differences located between the two potential splice-acceptor sites are both necessary and sufficient in defining the respective splicing patterns. One of these bases may serve as a lariat branch point critical for the alternative acceptor site activity while the remaining two bases appear to modulate the frequency with which this site is selected.
No takes yet. Share an insight, caveat, or question.
Estes et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: